Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125.

Incidence, extent, and time of seed loss after retropubic I-125 implantation was assessed in 52 patients treated for prostatic carcinoma. Radiographic controls up to 62 months were done to evaluate losses. Ninety percent of all patients lost seeds, averaging 8% of total implant number. Loss most frequently occurred within the first month by transurethral routes. Monitoring for seed loss is mandatory to assess dose deficit or inhomogeneous dose distribution, and to avoid environmental radiation hazards.

[1]  K. Charyulu.  Transperineal interstitial implantation of prostate cancer: a new method. , 1980, International journal of radiation oncology, biology, physics.

[2]  H. Sommerkamp,et al.  Die interstitielle Strahlentherapie des Prostatakarzinoms mit Jod125: Klinischer Erfahrungsbericht (vorläufige Mitteilung) , 1982 .

[3]  L L Anderson,et al.  Spacing nomograph for interstitial implants of 125I seeds. , 1976, Medical physics.

[4]  W. Renner,et al.  Computer assistance in planning radiotherapy seed implants. , 1979, International journal of radiation oncology, biology, physics.

[5]  L. Anderson,et al.  Dose inhomogeneity in interstitial implants using 125I seeds. , 1979, International journal of radiation oncology, biology, physics.

[6]  R. Virag,et al.  Effects of prostaglandin E1 on penile erection and erectile failure. , 1987, The Journal of urology.

[7]  K. A. Forbes,et al.  Preliminary observations on the results of combined temporary 192iridium implantation and external beam irradiation for carcinoma of the prostate. , 1986, The Journal of urology.

[8]  A. Moss,et al.  Value of computed tomography in interstitial 125I brachytherapy of prostatic carcinoma. , 1983, Radiology.

[9]  Interstitial volume implants with I-125 seeds. , 1981, International journal of radiation oncology, biology, physics.

[10]  J. Belis,et al.  Clinical results of early stage prostatic cancer treated by pelvic lymphadenectomy and 125iodine implants. , 1982, The Journal of urology.

[11]  W. Whitmore,et al.  125I Implantation of the Prostate: Dose-Response Considerations , 1978 .

[12]  W. Whitmore,et al.  Interstitial radiation: short-term palliation or curative therapy? , 1985, Urology.

[13]  P. Schellhammer,et al.  Major rectal complications following interstitial implantation of 125iodine for carcinoma of the prostate. , 1985, The Journal of urology.

[14]  M. R. Wheeler,et al.  Use of a caliper to determine dimensions of the volume to be implanted with 125iodine in the treatment of prostatic carcinoma. , 1978, The Journal of urology.

[15]  P. Schellhammer,et al.  Histological characteristics of prostatic biopsies after 125iodine implantation. , 1980, The Journal of urology.

[16]  H. Holm,et al.  Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.

[17]  C. Geard,et al.  Glutathione levels and cytotoxicity of a thiol activated alkylating agent in human and mouse cells. , 1986, International Journal of Radiation Oncology, Biology, Physics.

[18]  J. A. del Regato,et al.  The value of radiotherapy for Peyronie's disease: presentation of 56 new case studies and review of the literature. , 1980, International journal of radiation oncology, biology, physics.

[19]  U. Henschke,et al.  Dimension averaging a simple method for dosimetry of interstitial implants. , 1968, Radiobiologia, radiotherapia.

[20]  P. Guinan,et al.  Prostatorectal fistula associated with 125iodine seed radiotherapy. , 1983, The Journal of urology.

[21]  W. Shipley,et al.  Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.

[22]  C. E. Carlton,et al.  Radiotherapy in the management of stage C carcinoma of the prostate. , 1976, Transactions of the American Association of Genito-Urinary Surgeons.